Cambridge Investment Research Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-13,082	Closed	-$37K	–	2551
2020 Q1	$37K	Buy	+13,082	New	+$42.2K	﹤0.01%	2208
2018 Q4	–	Sell	-12,704	Closed	-$33K	–	2364
2018 Q3	$33K	Sell	12,704 -4,773	-27%	-$11.7K	﹤0.01%	2210
2018 Q2	$41K	Sell	17,477 -10,546	-38%	-$29.4K	﹤0.01%	2169
2018 Q1	$82K	Sell	28,023 -3,888	-12%	-$10.6K	﹤0.01%	2071
2017 Q4	$87K	Sell	31,911 -9,117	-22%	-$28K	﹤0.01%	2038
2017 Q3	$139K	Sell	41,028 -94	-0.2%	-$261	﹤0.01%	1890
2017 Q2	$102K	Sell	41,122 -4,844	-11%	-$11.1K	﹤0.01%	1848
2017 Q1	$104K	Buy	45,966 +104	+0.2%	+$230	﹤0.01%	1694
2016 Q4	$97K	Buy	45,862 +7,194	+19%	+$20.1K	﹤0.01%	1590
2016 Q3	$130K	Buy	38,668 +3,357	+10%	+$10.7K	﹤0.01%	1646
2016 Q2	$111K	Sell	35,311 -38,788	-52%	-$129K	﹤0.01%	1474
2016 Q1	$247K	Buy	74,099 +731	+1%	+$2.28K	0.01%	1280
2015 Q4	$260K	Sell	73,368 -5,073	-6%	-$21.2K	0.01%	1195
2015 Q3	$395K	Buy	78,441 +6,256	+9%	+$35.8K	0.01%	886
2015 Q2	$464K	Buy	72,185 +48,282	+202%	+$323K	0.01%	850
2015 Q1	$168K	Buy	+23,903	New	+$173K	﹤0.01%	1287

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Cambridge Investment Research Advisors's PDLI Position: Q2 2020 in Review

Cambridge Investment Research Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2020, closing a stake of 13,082 shares — an estimated $37K sold.

Cambridge Investment Research Advisors first reported a position in PDLI in Q1 2015 and held it in 16 quarters. The position peaked at $464K in Q2 2015. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.

Cambridge Investment Research Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2020 after selling out during the quarter.
Cambridge Investment Research Advisors sold 13,082 PDL BioPharma, Inc. shares in Q2 2020, an estimated $37K.
Cambridge Investment Research Advisors first reported a position in PDL BioPharma, Inc. in Q1 2015 and held it in 16 quarters.
Cambridge Investment Research Advisors's PDL BioPharma, Inc. position peaked at $464K in Q2 2015.
136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.